| Topical drug treatment in acne. | |
| | |
MedLine Citation:
|
PMID: 9557245 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The main part of acne treatment uses the topical route. More than 50% of acne patients belong to the group presenting with acne comedonica and papulopustulosa. Whenever small nodes or scarring occur, systemic comedication is indicated, however. Topical treatment affects at least three of the four main pathogenetic factors responsible for the development of acne, i.e. hyperseborrhea, hyperkeratosis, microbial colonization and inflammation. The agents currently available influence at least one of these factors but often have additional properties. Those which act in a comedolytic and anticomedogenic manner are the retinoids tretinoin, isotretinoin, adapalene and tazarotene and azelaic acid as well, some of the retinoids having additional anti-inflammatory potency. Azelaic acid has strong antibacterial potency without inducing bacterial resistance similar to benzoyl peroxide. Unfortunately, bacterial resistances are beginning to emerge as a significant problem. Propionibacterium acnes resistance to the commonly used erythromycin can also be transferred to clindamycin, whereas no resistance has been reported to nadifloxacin so far. Today, more and more evidence comes up that topical antiandrogenic agents will soon be available to treat the important factor seborrhea, because patients with marked hyperseborrhea frequently relapse. Finally, liposome encapsulation of agents including phospholipids can enhance penetration and efficacy but, particularly with regard to retinoids, can lead to higher absorption and adverse drug reactions. |
| | |
Authors:
|
H Gollnick; M Schramm |
Related Documents
:
|
12005065 - Myrsinoic acids b, c and f, anti-inflammatory compounds from myrsine seguinii. 14502755 - Synthesis and analgesic and anti-inflammatory activity of some new (6-acyl-2-benzoxazol... 14563345 - Preconditioning and metabolic anti-ischaemic agents. 9776475 - Anti-arthritic effects of the novel dipeptidyl peptidase iv inhibitors tmc-2a and tsl-225. 2866465 - Ketamine acts as a non-competitive n-methyl-d-aspartate antagonist on frog spinal cord ... 1860645 - Microanalysis of bile acid composition in intrahepatic calculi and its etiological sign... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Dermatology (Basel, Switzerland) Volume: 196 ISSN: 1018-8665 ISO Abbreviation: Dermatology (Basel) Publication Date: 1998 |
Date Detail:
|
Created Date: 1998-06-22 Completed Date: 1998-06-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9203244 Medline TA: Dermatology Country: SWITZERLAND |
Other Details:
|
Languages: eng Pagination: 119-25 Citation Subset: IM |
Affiliation:
|
Department of Dermatology and Venereology Medical Faculty, Otto von Guericke University, Magdeburg, Germany. harald.gollnick@medizin.uni.magdeburg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acne Vulgaris
/
drug therapy* Administration, Topical Anti-Bacterial Agents / administration & dosage Benzoyl Peroxide / administration & dosage Dermatologic Agents / administration & dosage* Dicarboxylic Acids / administration & dosage Humans Keratolytic Agents / administration & dosage* Retinoids / administration & dosage |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Dermatologic Agents; 0/Dicarboxylic Acids; 0/Keratolytic Agents; 0/Retinoids; 123-99-9/azelaic acid; 94-36-0/Benzoyl Peroxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Psychotherapeutic approach in acne treatment.
Next Document: New insight into the topical management of excessive sebum flow at the skin surface.